Serosep are leading suppliers of cutting edge molecular diagnostic tests for reliable results across many applications.
PathoNostics was founded in 2011 in Maastricht, The Netherlands and became an important player in the fungal diagnostic field. PathoNostics is focussing on the development and commercialization of real-time PCR kits for the diagnosis of superficial and invasive fungal infections. PathoNostics currently has four products on the market: AsperGenius®, DermaGenius®, PneumoGenius® and MucorGenius®.
PCR kits from PathoNostics enable a rapid and accurate diagnosis, leading to timely initiation of targeted therapy. The proprietary technology platform uses real-time PCR and melting curve analysis to detect and differentiate pathogens and identify resistance markers.
Founded in 2009, SpeeDx is an Australian-based private company with offices in London and the US, and distributors across Europe. SpeeDx specialize in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease.